Pneumonia is a common cause of critical illness in the intensive care unit (ICU), and some patients deteriorate rapidly to respiratory failure requiring invasive mechanical ventilation (IMV). Decisions about escalating respiratory support often rely on fragmented clinical indicators. The study aimed to create an integrated, data‑driven tool to predict the need for IMV within 24 hours of ICU admission for patients with pneumonia, with emphasis on interpretability and potential clinical utility.
The authors conducted a retrospective cohort study using the Medical Information Mart for Intensive Care IV (MIMIC‑IV) database as the development dataset. The development cohort contained 5,608 ICU patients with pneumonia. The cohort was randomly split into training (80%) and test (20%) sets for model development and internal evaluation. An independent external validation cohort from Maoming People's Hospital was used to assess generalizability.
Candidate predictors were restricted to variables available at ICU admission. The manuscript reports a multi‑step feature selection process that reduced the candidate list to seven predictors retained in the final model: age, oxygen flow, FiO2, pH, PaO2, PaCO2, and platelet count. The exact details of each feature selection step (specific methods, thresholds or intermediate candidate lists) were described in the source but are summarized here as a multi‑step selection that yielded a compact predictor set.
Eight machine learning algorithms were trained using the development dataset. Training incorporated 5‑fold cross‑validation and hyperparameter tuning for each algorithm. Model performance during internal testing was assessed using standard metrics for predictive models, including discrimination and calibration. Among the tested algorithms, LightGBM provided the best performance on the internal test set.
The best‑performing model (LightGBM) was externally validated in an independent cohort from Maoming People's Hospital comprising 155 patients. External validation assessed whether predictive performance and calibration observed internally were maintained in a separate clinical population.
In the development cohort, 856 of 5,608 patients (15.3%) required IMV within 24 hours of ICU admission. LightGBM achieved an area under the receiver operating characteristic curve (AUC) of 0.799 in the internal test set. In external validation (n = 155), the model achieved an AUC of 0.702. Calibration was reported as showing acceptable agreement between predicted probabilities and observed outcomes. Decision curve analysis demonstrated a net clinical benefit across thresholds evaluated by the authors, supporting potential clinical utility of the model as an adjunctive decision aid.
To enhance interpretability, the authors applied SHAP (Shapley Additive Explanations) analysis. SHAP identified and quantified the contribution of individual predictors to model risk estimates, facilitating clinician understanding of why a particular patient received a higher or lower predicted risk of early IMV. The seven retained predictors were highlighted by SHAP as key drivers of risk in the final model.
The model enabled risk stratification into groups with progressively increasing observed incidence of IMV, allowing identification of clinically distinct strata at admission. The authors reported that stratification could help clinicians prioritize monitoring and interventions for patients at higher predicted risk. Exact risk thresholds and strata definitions used for stratification were derived from the model outputs and the decision curve analysis described in the source.
A web‑based calculator was developed to facilitate individualized risk assessment at the point of care. The online tool implements the final LightGBM model and allows clinicians to input the seven admission variables to obtain a predicted probability of requiring IMV within 24 hours. The source reports the calculator as a step toward clinical deployment, though prospective evaluation in routine care was recommended.
The study developed and externally validated a machine learning model to predict early IMV in ICU patients admitted with pneumonia, using seven admission variables. LightGBM showed the best internal discrimination (AUC = 0.799) and achieved moderate discrimination on external validation (AUC = 0.702; external n = 155). Calibration was acceptable and decision curve analysis suggested net clinical benefit. The model is interpretable via SHAP and is available as an online calculator to support individualized risk stratification. The authors conclude that the model may serve as an adjunctive tool to assist clinical decision‑making and recommend multicenter prospective studies to confirm clinical utility and impact on patient outcomes.
The source reports the study design, cohort sizes, predictor set, modeling procedures (including 5‑fold cross‑validation and hyperparameter tuning), performance metrics, SHAP interpretability, and the existence of an online calculator. The source recommends multicenter prospective validation to confirm clinical utility. If additional details on feature selection thresholds, full variable lists considered, or prospective impact on outcomes are required, these were not fully enumerated in the abstract and would require consultation of the full text.